|
?:authorAffiliation
|
-
[\'Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia. Electronic address: dene.littler@monash.edu.\', \'Griffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia.\', \'Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia.\', \'Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA.\', \'Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.\', \'Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.\', \'Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, USA; Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA.\', \'Griffith Institute for Drug Discovery, Griffith University, Brisbane, Queensland, Australia; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria, Australia. Electronic address: r.quinn@griffith.edu.au.\', \'Infection and Immunity Program & Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia; Institute of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom. Electronic address: jamie.rossjohn@monash.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}